ITGAX and neoplasm: Consistently, we found RA‐treated tumors displayed higher levels of infiltrating CD103+ CD11c+ DCs than the control group, and RA failed to suppress the tumor growth in cDC1‐depleted mice, suggesting a critical role of cDC1 in immune recognition and elimination of tumor.